From a once-dismissed folk remedy to a highly sought-after treatment option, medical marijuana has earned a place at the table, forcing a re-evaluation of how we approach some of the most challenging medical conditions.
Doctors most often recommend medical marijuana for a specific set of debilitating conditions that fail to respond adequately to conventional treatments. Technically speaking, plant-based marijuana products in the US are not “prescribed” because it is not FDA-approved and don’t come from pharmacies (but synthetic cannabinoids are and can). Cannabis-based therapies can only be “recommended” by licensed doctors based on state’ rules.
The majority of patients seeking medical marijuana do so for pain management. However, doctors commonly recommend medical marijuana not only for chronic pain but also commonly post-traumatic stress disorder (PTSD), cancer-related symptoms, and various neurological conditions.
A 2025 analysis found that chronic pain is, by a significant margin, the most prevalent reason for medical cannabis certification. Similarly, PTSD has become a leading reason for medical marijuana recommendations. Many states have added PTSD to their list of qualifying conditions, acknowledging the role of cannabis in managing symptoms such as anxiety, insomnia, nightmares, and hypervigilance.
Patients and doctors widely use medical marijuana or pharmaceutical cannabinoids (e.g., dronabinol, nabilone) to ease the debilitating side effects of cancer and its treatments. Doctors often recommend these to manage chemotherapy-induced nausea, vomiting, and loss of appetite. Synthetic THC can be prescribed here, although people can usually better afford and tolerate plant-based cannabis.
Patients also rely on medical marijuana to treat several neurological conditions, especially epilepsy and multiple sclerosis (MS). For individuals with drug-resistant epilepsy, cannabis-based products, particularly those high in CBD, may help effectively reduce seizure frequency – demonstrated in children.
The most prevalent condition for medical marijuana use. This is a broad category that includes severe and persistent pain from various ailments, such as neuropathic pain, fibromyalgia, severe musculoskeletal back pain, and migraines.
The most common mental health condition by number of medical cannabis recommendations is post-traumatic stress disorder (PTSD). Many patients also find that cannabis helps to manage core symptoms of anxiety, severe insomnia, and recurring flashbacks. Tetrahydrocannabidiol (THC)-dominant cannabis may actively reduce anxiety, nightmares, insomnia, and depression symptoms, both in the short term and over sustained use.
For neurological health, epilepsy is a major focus. Similarly, multiple sclerosis (MS) patients frequently use medical marijuana to manage spasticity, muscle stiffness, and chronic pain.
Hence, medical cannabis may provide significant relief from a range of neurological symptoms, including tremors and spasticity in conditions like Parkinson’s disease.
Cannabis is also frequently recommended for chemotherapy-induced nausea, vomiting, and loss of appetite. The use of medical marijuana for these purposes often provides a significant improvement in the patient’s quality of life during treatment.
Yes, noncancer-related chronic pain is the most common reason for medical cannabis recommendations. The primary reason for this high prevalence is the ability of cannabis to manage pain with fewer side effects, lower dependence risk over opioids, and no risk of fatal overdose, making it a preferred option for both patients and a growing number of physicians.
The effectiveness of medical marijuana in managing chronic pain is based on its interaction with the endocannabinoid system (ECS), which plays a central role in regulating pain signals and inflammation throughout the body.
The two primary cannabinoids, THC and CBD, work together to produce their pain-relieving effects. THC binds directly to cannabinoid receptors (specifically CB1 receptors in the brain and CB2 receptors in the body’s immune cells), which helps to modulate and reduce the perception of pain. CBD reduces pain by increasing endocannabinoids, hitting non-CB pain-relieving targets (TRP), and targeting inflammation, which plays a key role in many chronic pain conditions. Together, these cannabinoids provide a dual-action effect that can significantly alleviate discomfort and act as a viable alternative to other pain medications.
Yes, medical marijuana can be recommended for mental health conditions – subject to state rules. For many patients, the therapeutic benefits of cannabis, particularly its calming and anxiolytic effects, provide much-needed relief from severe symptoms that may not respond to conventional treatments.
Of all the mental health conditions, PTSD has the highest acceptance for medical cannabis use. Patients with PTSD often seek cannabis to manage severe anxiety, insomnia, nightmares, and debilitating flashbacks. Medical cannabis may provide significant improvements in PTSD symptoms, anxiety, time to fall asleep, and sleep quality.
While clinicians widely accept PTSD as a qualifying condition, they view the use of medical cannabis for general anxiety and depression as more nuanced. Research shows that high doses of CBD can provide acute relief from anxiety by interacting with the endocannabinoid system (ECS), the network that regulates mood and stress. Although the most recent research suggests that the CBD dose-response curve for anxiety in PTSD may be more complex.
Researchers believe CBD reduces anxiety and depression by influencing serotonin receptors and enhancing the body’s natural mood-stabilizing compounds. Many people favor CBD because it delivers more consistent antianxiety effects.
THC, in contrast, may induce a calming effect at low doses by activating CB1 receptors, but at higher doses, it can paradoxically increase anxiety.
Meanwhile, CBG is another non-intoxicating, rising star for anxiety and chronic pain. A 2024 double-blind RCT found that just 20 mg of hemp-derived CBG was able to reduce anxiety and healthy adults, much less than CBD in clinical trials. Its antidepressant features are shown in mice, but are still being explored in people.
One of the most effective uses of medical cannabis is to combat chemotherapy-induced nausea and vomiting (CINV). Chemotherapy drugs can trigger severe sickness by affecting the brain’s vomiting center. The active compound THC is highly effective at binding to cannabinoid receptors in this region, which can significantly suppress nausea and vomiting. Patients often use FDA-approved, prescription synthetic THC (e.g., dronabinol or nabilone) or off-label, plant-based medical cannabis as a supportive therapy when standard antiemetic medications fail to control their nausea.
Another key application of medical cannabis is its ability to stimulate appetite for patients suffering from cancer-related anorexia and cachexia (a wasting syndrome characterized by severe weight loss). The THC in cannabis interacts with the body’s endocannabinoid system, activating receptors in the brain that regulate appetite. This interaction can lead to a significant increase in hunger, a well-known effect often referred to as “the munchies.” This is particularly valuable for patients who struggle with poor appetite and weight loss, which can compromise their strength and ability to endure treatment.
A wide range of neurological conditions commonly qualify for medical marijuana prescriptions. Cannabinoids create therapeutic effects by protecting nerves and interacting with the body’s endocannabinoid system, which actively regulates motor control and neural signaling.
One of the most significant applications of medical cannabis in neurology is for epilepsy, particularly for forms that are resistant to conventional treatments. The CBD component of cannabis has been shown to reduce the frequency and severity of seizures. Importantly, the FDA-approved drug Epidiolex, which is a purified, plant-derived CBD product, is a testament to this, as it is prescribed for the treatment of severe, specific types of epilepsy.
Multiple Sclerosis (MS) is another common qualifying condition. Many patients with MS use medical marijuana to manage debilitating symptoms such as muscle spasticity, stiffness, and chronic pain. The anti-inflammatory and muscle-relaxing properties of cannabinoids can provide significant relief where other treatments have failed.
The best proof lies in nabiximols (Sativex®), a 1:1 THC:CBD oral spray formulation that is approved and available in over 30 countries outside the US. Nabiximols is not FDA-approved, unfortunately, so it cannot be prescribed. Similar formulas may be found in dispensaries, but are not yet shown to be equivalent generics.
Medical marijuana is also increasingly used to manage symptoms of Parkinson’s disease, such as tremors, rigidity, and dyskinesia. A 2025 observational study found that patients who used medical cannabis reported a reduction in tremors and stiffness, suggesting a potential for cannabinoid-based therapies to help with motor symptoms.
READ: Marijuana Recommendation vs. Marijuana Prescription
Yes, chronic pain is the most common reason for medical cannabis recommendations, consistently ranking as the leading qualifying condition. It is often comorbid; not the only diagnosis being treated. Cannabis has many therapeutic mechanisms of action, combined with high patient satisfaction and the benefit of being a safer alternative to opioids, making it a preferred treatment option for a wide range of patients.
It is possible to get medical marijuana for anxiety, depending on state law. Although some states list it as a qualifying condition, others allow for its use under a more general category, such as severe chronic pain or as a symptom of PTSD. A few lax states will also allow doctors to recommend cannabis for anything they think it could help with.
Yes, cancer patients very commonly qualify for medical marijuana, primarily for its use in palliative care to manage symptoms rather than as a cure for the disease itself. There are also 2 FDA-approved prescriptions for synthetic THC available.
This means that cancer patients seek either pharmaceutical or plant-based medical marijuana as an option to combat the harsh side effects of chemotherapy, such as severe nausea and vomiting, to stimulate appetite, and to prevent or reverse weight loss. The plant-based cannabis medicines are not FDA-approved, but are cheaper, more accessible, and better tolerated.
Insomnia rarely qualifies as a standalone condition for medical marijuana. However, doctors frequently address it as a major symptom of other underlying qualifying conditions.
For example, patients with PTSD, chronic pain, or anxiety often experience severe and chronic insomnia — and all three are widely accepted as qualifying conditions. Insomnia is comorbid with many severe conditions, and so it’s more likely to qualify with one of those.
Medical marijuana programs most commonly recognize PTSD as a qualifying mental health diagnosis. Some programs also allow patients with severe anxiety and depression to qualify, but they rarely list these conditions as standalone qualifiers.
In states that do not list anxiety or depression as qualifying conditions, a patient may still be approved for a medical marijuana card if the doctor determines that the patient’s condition is so severe that it falls under a more general category for “chronic” conditions. This can also happen if the anxiety or depression is a direct symptom of another qualifying condition, such as chronic pain or PTSD.
Yes, doctors frequently recommend medical marijuana to alleviate PTSD, making it one of the most common mental health conditions managed with cannabis. Patients with PTSD often find therapeutic relief from medical cannabis for some symptoms, such as severe anxiety, insomnia, nightmares, and recurring flashbacks.
Yes, patients commonly qualify for a medical marijuana card with arthritis. Physicians typically certify it under the broader category of chronic pain, which ranks as the most common reason people use medical cannabis.
Patients also use medical cannabis to manage symptoms of various forms of arthritis, including rheumatoid arthritis, JIA, osteoarthritis, and more.
No Information on MarijuanaDoctors.Com should be used to diagnose, treat, prevent or cure any disease or condition. You can view our Full Disclaimer here.
Please allow us to access your location to find local dispensaries.
VIEW ALL DISPENSARIES ➔
